Patents
Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
09/2012
09/19/2012CN101460467B Diarylthiohydantoin compounds
09/18/2012CA2771069C Salts comprising cyanoborate anions
09/18/2012CA2273083C Synthesis of epothilones, intermediates thereto, analogues and uses thereof
09/13/2012WO2012119559A1 Androgen receptor antagonists and uses thereof
09/13/2012WO2012119212A1 Imidazolidine and thiazolidine molecules with anti-t. cruzi activity
09/13/2012US20120232287 Detergent dispersant and lubricating oil composition
09/13/2012US20120232286 Azole derivatives, methods for producing the same, intermediate thereof, agro-horticultural agents
09/13/2012US20120232120 Amino acid amides of phenoxybutyric acid derivatives
09/13/2012US20120230986 Agent and Methods for Reducing Inflammatory Markers
09/13/2012US20120227545 Aqueous leaching process for recovery of precious metals with addition of di-thiooxamide ligand
09/13/2012CA2829322A1 Androgen receptor antagonists and uses thereof
09/12/2012CN102666494A Aminomethyl-substituted imidazole compounds for use as friction modifiers in lubricating oil compositions
09/12/2012CN102659823A Amino acid copper complex with effects of preventing alopecia, growing hair growth and protecting skin, preparation method and application
09/12/2012CN102659685A Process for preparing N-substituted azole derivatives under the catalytic action of metallic iron salt
09/12/2012CN102659684A Device and method for preparing hydantoin
09/12/2012CN102659683A Process for production of 5-alkoxy-4-hydroxymethylpyrazole compound
09/12/2012CN102659682A Imidazole side chain half-metallocene imine ligand, and method and application thereof
09/12/2012CN102659681A Process for preparing imidazoline cationic asphalt emulsifier used for micro-surfacing
09/12/2012CN102659615A Derivatives of oseltamivir, and method and medical application thereof
09/12/2012CN102658199A Novel asymmetric phase-transfer catalyst pentaazabicyclo and preparation method thereof
09/12/2012CN102020611B Method for preparing allantoin from nitraria core residue
09/11/2012US8263635 Inhibitors of CYP 17
09/11/2012US8263634 Heteroaryl-ureas and their use as glucokinase activators
09/11/2012US8263608 Melanocortin receptor-specific spiro-piperidine compounds
09/11/2012CA2558506C Mtp inhibiting aryl piperidines or piperazines substituted with 5-membered heterocycles
09/11/2012CA2445159C Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
09/06/2012US20120226051 Organic dicarboxylic acids, salts and preparation method thereof
09/06/2012US20120226048 Paramagnetic Polynuclear Metal Complex Having High Self-Relaxation Rate, Preparation Method Thereof, and Contrast Medium Containing Same
09/06/2012US20120222557 Ionic liquids comprising heteraromatic anions
09/05/2012EP2494993A2 Amino acid lipids and uses thereof
09/05/2012EP2493862A1 Imidazole derivatives as ido inhibitors
09/05/2012EP2493861A1 Methods of preparing 1-(4-((1r,2s,3r)-1,2,3,4-tetrahydroxybutyl)-1h-imidazol-2-yl)ethanone
09/05/2012EP2493571A1 Alkynyl derivatives useful as dpp-1 inhibitors
09/05/2012CN102656150A Normal-temperature molten salt, electrode, cell, agent for preventing charge-up, and method for observing sample
09/05/2012CN102655883A GLP-1 receptor agonist compounds with a modified N-terminus
09/05/2012CN102653571A Compound used for controlling environmental pollution and preparation and regeneration methods thereof
09/05/2012CN101870680B Preparation method and use of tertiary amino functional imidazole ionic liquid
09/05/2012CN101657470B Reformation of ionic liquids
09/05/2012CN101386597B Alkyl imidazoles perrhenate ion liquid and preparation method thereof
09/05/2012CN101250159B Chloride 1,3-di(2-methoxy-2-yloxyethyl) imidazole ionic liquid and method for synthesizing same
09/04/2012US8258343 Prevention of cellular senescence in mammals by natural peptide complexes
09/04/2012US8258294 Process for the preparation of temozolomide and analogs
09/04/2012US8258166 Pharmaceutical composition
09/04/2012US8258165 Pharmaceutical composition
09/04/2012US8258141 Organic compounds
09/04/2012CA2700679C Novel crystal form of 5-hydroxy-1-methylhydantoin
09/04/2012CA2501819C Imidazole derivative and their use as peripherally-selective inhibitors of dopa nine-beta-hydroxylase
08/2012
08/30/2012US20120219500 Diagnostic agent for infectious diseases
08/29/2012CN102649904A Iridium-containing organic electroluminescent material, preparation method thereof and organic electroluminescent device
08/29/2012CN102649903A Iridium-containing organic electroluminescent material, preparation method thereof and organic electroluminescent device
08/29/2012CN102649796A Preparation method for important intermediates of butoconazole nitrate
08/29/2012CN101830853B Nitroimidazoline derivatives and preparation method thereof and application thereof
08/28/2012US8252944 Process for preparing heteroaromatic ring compound having N-Rf group
08/28/2012US8252943 Method for the production of compounds with quaternary sp2-hybridised nitrogen atoms
08/28/2012US8252942 Substituted imidazoline compounds
08/28/2012US8252923 Peptidomimetic protease inhibitors
08/28/2012US8252843 Compounds for the treatment of AIDS and other viral diseases
08/28/2012US8252832 Kinesin inhibitors as cancer therapeutics
08/28/2012US8252831 Imidazole-2-benzamide compounds useful for the treatment of osteoarthritis
08/28/2012US8252829 Aminopyrrolidinone derivatives and uses thereof
08/28/2012CA2513746C Pharmaceutical co-crystal compositions of drugs such as carbamazeptine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen
08/28/2012CA2433832C Composition and method for bleaching a substrate
08/23/2012WO2012111462A1 Organic electroluminescence element and illumination device
08/23/2012US20120215004 Preparation of a lead-free primary explosive
08/23/2012US20120214849 Dual-acting antihypertensive agents
08/23/2012US20120214808 Aryl Urea Derivatives for Treating Obesity
08/23/2012US20120213806 Neprilysin inhibitors
08/22/2012EP2489350A1 N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors
08/22/2012CN102648185A Methods of preparing 1-(4-((1r,2s,3r)-1,2,3,4-tetrahydroxybutyl)-1h-imidazol-2-yl)ethanone
08/22/2012CN102648184A LXR modulators
08/22/2012CN102643640A Shape-controlled iridium metal complex organic fluorescence nano particle and preparation method thereof
08/22/2012CN102643238A Preparation and purification method for new ornidazole optical antimer
08/22/2012CN102643237A Method for preparing 1H-imidazole-4-formic acid
08/22/2012CN102643236A Method for preparing chiral amide imidazolium bromide ionic liquid from natural amino acid
08/22/2012CN102643235A Method for the production of n,n -carbonyldiazoles
08/22/2012CN101723900B Cinnamide compound
08/21/2012US8247432 Tripeptidyl peptidase inhibitors
08/21/2012US8247117 Ionic liquid
08/16/2012WO2012107850A1 Glucagon receptor modulator
08/16/2012WO2012050918A8 Tricyclic fused ring inhibitors of hepatitis c
08/16/2012WO2004053071A9 Method for discovering neurogenic agents
08/16/2012US20120209012 Compounds, compositions and methods
08/16/2012US20120209008 Process for preparing biphenyl imidazole compounds
08/16/2012CA2825102A1 Glucagon receptor modulators
08/15/2012EP2486020A1 Method for the synthesis of ergothioneine and the like
08/15/2012EP2486019A1 Method for the synthesis of 2-thiohistidine and the like
08/15/2012EP1438295B1 Azole derivatives and pharmaceutical compositions containing them
08/15/2012CN1781914B Organic polymer and novel polymerizable compound
08/15/2012CN102639509A Azole derivatives, methods for producing the same, intermediate thereof, agro-horticultural agents
08/15/2012CN102639508A Azole derivatives and methods for producing the same, intermediate compounds for the derivatives and methods for producing the same, and agro-horticultural agents and industrial material protecting agents containing the derivatives
08/15/2012CN102633927A Ionic liquid modified carbine, preparation method for same and application thereof
08/15/2012CN102633725A Synthetic method of N-heptafluorobutyrylimidazole
08/15/2012CN102633724A Amino acid imidazolium ionic liquid and preparation method thereof
08/15/2012CN102633723A Preparation method of ozagrel
08/15/2012CN101479299B Hafnium complexes of heterocyclic organic ligands
08/15/2012CN101307046B Tripeptidyl peptidase inhibitors
08/14/2012US8242260 Compounds and compositions as protein kinase inhibitors
08/14/2012US8242159 1,3-dihydro-5-isobenzofurancarbonitrile derivatives and pharmaceutical composition thereof for the treatment of premature ejaculation
08/14/2012US8242117 5-membered heterocycle-based p38 kinase inhibitors
08/14/2012US8242115 Materials and methods to potentiate cancer treatment
1 ... 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 ... 345